Activation of Stat3 by Heregulin/ErbB-2 Through the Co-Option of Progesterone Receptor Signaling Drives Breast Cancer Growth

Molecular and Cellular Biology - United States
doi 10.1128/mcb.00853-08
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology

Related search

Progesterone Receptor Induces ErbB-2 Nuclear Translocation to Promote Breast Cancer Growth via a Novel Transcriptional Effect: ErbB-2 Function as a Coactivator of Stat3

Molecular and Cellular Biology
Cell BiologyMolecular Biology
2010English

Genetic Prodrug Activation in erbB-2 Overexpressing Breast Cancer

Breast Cancer Research
Cancer ResearchOncology
1999English

Heregulin Β1 Drives Gefitinib-Resistant Growth and Invasion in Tamoxifen-Resistant McF-7 Breast Cancer Cells

Breast Cancer Research
Cancer ResearchOncology
2007English

Cyclooxygenase-2 Immunoexpression in Breast Cancer: Progesterone Receptor Influence

Cancer Epidemiology
Cancer ResearchEpidemiologyOncology
2011English

Role of STAT3 Signaling Pathway in Breast Cancer

Cell Communication and Signaling
BiochemistryCell BiologyMolecular Biology
2020English

Ibrutinib Inhibits ERBB Receptor Tyrosine Kinases and HER2-Amplified Breast Cancer Cell Growth

Molecular Cancer Therapeutics
Cancer ResearchOncology
2016English

A Meta-Analysis of Oestrogen Receptor, Progesterone Receptor and Human Epidermal Growth Factor Receptor 2 Discordance Between Primary Breast Cancer and Metastases

European Journal of Cancer
Cancer ResearchOncology
2014English

Study of the Regulation of ErbB Signaling by Receptor-Mediated Endocytosis

2002English

ErbB-2 Nuclear Function in Breast Cancer Growth, Metastasis and Resistance to Therapy

Endocrine-Related Cancer
Cancer ResearchEndocrinologyOncologyMetabolismDiabetes
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy